Wynnefield Capital’s Lifecore Biomedical LFCR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $38.2M | Hold |
|
|||||
2025
Q1 | $33.1M | Hold |
|
|||||
2024
Q4 | $34.9M | Sell |
|
|||||
2024
Q3 | $24.3M | Hold |
|
|||||
2024
Q2 | $25.2M | Sell |
|
|||||
2024
Q1 | $26.1M | Hold |
|
|||||
2023
Q4 | $30.5M | Hold |
|
|||||
2023
Q3 | $37.1M | Hold |
|
|||||
2023
Q2 | $47.6M | Hold |
|
|||||
2023
Q1 | $18.6M | Buy |
|
|||||
2022
Q4 | $28.9M | Buy |
|
|||||
2022
Q3 | $31.4M | Hold |
|
|||||
2022
Q2 | $35.2M | Hold |
|
|||||
2022
Q1 | $40.9M | Buy |
|
|||||
2021
Q4 | $34.9M | Hold |
|
|||||
2021
Q3 | $29M | Hold |
|
|||||
2021
Q2 | $35.4M | Buy |
|
|||||
2021
Q1 | $30.7M | Buy |
|
|||||
2020
Q4 | $31.3M | Buy |
|
|||||
2020
Q3 | $27.9M | Hold |
|
|||||
2020
Q2 | $22.9M | Buy |
|
|||||
2020
Q1 | $24.9M | Hold |
|
|||||
2019
Q4 | $32.5M | Hold |
|
|||||
2019
Q3 | $31.2M | Buy |
|
|||||
2019
Q2 | $26.2M | Buy |
|
|||||
2019
Q1 | $33.6M | Buy |
|
|||||
2018
Q4 | $31.8M | Hold |
|
|||||
2018
Q3 | $38.6M | Hold |
|
|||||
2018
Q2 | $40M | Hold |
|
|||||
2018
Q1 | $35M | Hold |
|
|||||
2017
Q4 | $33.8M | Hold |
|
|||||
2017
Q3 | $34.7M | Hold |
|
|||||
2017
Q2 | $39.8M | Hold |
|
|||||
2017
Q1 | $32.2M | Hold |
|
|||||
2016
Q4 | $37M | Hold |
|
|||||
2016
Q3 | $36M | Hold |
|
|||||
2016
Q2 | $28.9M | Hold |
|
|||||
2016
Q1 | $28.2M | Hold |
|
|||||
2015
Q4 | $31.7M | Buy |
|
|||||
2015
Q3 | $31.1M | Buy |
|
|||||
2015
Q2 | $38.2M | Hold |
|
|||||
2015
Q1 | $37M | Hold |
|
|||||
2014
Q4 | $36.6M | Buy |
|
|||||
2014
Q3 | $30M | Buy |
|
|||||
2014
Q2 | $21.4M | Hold |
|
|||||
2014
Q1 | $19.1M | Buy |
|
|||||
2013
Q4 | $19.1M | Hold |
|
|||||
2013
Q3 | $19.2M | Sell |
|
|||||
2013
Q2 | $22.9M | Buy |
|